Skip to main content
Addgene

Combating Drug Resistance by Exploiting miRNA-200c-Controlled Phase II Detoxification.

Kohler B, Dubovik S, Horterer E, Wilk U, Stockl JB, Tekarslan-Sahin H, Ljepoja B, Paulitschke P, Frohlich T, Wagner E, Roidl A
Cancers (Basel). 2022 Nov 11;14(22):5554. doi: 10.3390/cancers14225554. (Link opens in a new window) PubMed (Link opens in a new window) Article

Plasmids from Article

No plasmids are currently publicly available from Addgene for this article.

Antibodies from Article